Garrido Claudia, Leimkühler Silke
Institute of Biochemistry and Biology, Department of Molecular Enzymology, University of Potsdam, Potsdam, Germany.
Institute of Biochemistry and Biology, Department of Molecular Enzymology, University of Potsdam, Potsdam, Germany
Drug Metab Dispos. 2021 Sep;49(9):729-735. doi: 10.1124/dmd.121.000549. Epub 2021 Jun 28.
Mammalian aldehyde oxidases (AOX) are molybdo-flavoenzymes of pharmacological and pathophysiologic relevance that are involved in phase I drug metabolism and, as a product of their enzymatic activity, are also involved in the generation of reactive oxygen species. So far, the physiologic role of aldehyde oxidase 1 in the human body remains unknown. The human enzyme hAOX1 is characterized by a broad substrate specificity, oxidizing aromatic/aliphatic aldehydes into their corresponding carboxylic acids, and hydroxylating various heteroaromatic rings. The enzyme uses oxygen as terminal electron acceptor to produce hydrogen peroxide and superoxide during turnover. Since hAOX1 and, in particular, some natural variants produce not only HO but also high amounts of superoxide, we investigated the effect of both ROS molecules on the enzymatic activity of hAOX1 in more detail. We compared hAOX1 to the high-O -producing natural variant L438V for their time-dependent inactivation with HO/O during substrate turnover. We show that the inactivation of the hAOX1 wild-type enzyme is mainly based on the production of hydrogen peroxide, whereas for the variant L438V, both hydrogen peroxide and superoxide contribute to the time-dependent inactivation of the enzyme during turnover. Further, the level of inactivation was revealed to be substrate-dependent: using substrates with higher turnover numbers resulted in a faster inactivation of the enzymes. Analysis of the inactivation site of the enzyme identified a loss of the terminal sulfido ligand at the molybdenum active site by the produced ROS during turnover. SIGNIFICANCE STATEMENT: This work characterizes the substrate-dependent inactivation of human aldehyde oxidase 1 under turnover by reactive oxygen species and identifies the site of inactivation. The role of ROS in the inhibition of human aldehyde oxidase 1 will have a high impact on future studies.
哺乳动物醛氧化酶(AOX)是具有药理学和病理生理学相关性的钼黄素酶,参与I相药物代谢,并且作为其酶活性的产物,也参与活性氧的生成。到目前为止,醛氧化酶1在人体中的生理作用仍然未知。人源酶hAOX1的特点是具有广泛的底物特异性,可将芳香族/脂肪族醛氧化为相应的羧酸,并使各种杂芳环羟基化。该酶在周转过程中使用氧气作为末端电子受体来产生过氧化氢和超氧化物。由于hAOX1,特别是一些天然变体不仅产生HO,还产生大量超氧化物,我们更详细地研究了这两种活性氧分子对hAOX1酶活性的影响。我们比较了hAOX1和产生高O的天然变体L438V在底物周转过程中与HO/O的时间依赖性失活情况。我们发现,hAOX1野生型酶的失活主要基于过氧化氢的产生,而对于变体L438V,过氧化氢和超氧化物在周转过程中都导致酶的时间依赖性失活。此外,失活水平显示出底物依赖性:使用周转数较高的底物会导致酶更快失活。对酶失活位点的分析确定,在周转过程中产生的活性氧会导致钼活性位点的末端硫醇配体丢失。意义声明:这项工作表征了人醛氧化酶1在周转过程中被活性氧底物依赖性失活的情况,并确定了失活位点。活性氧在抑制人醛氧化酶1中的作用将对未来的研究产生重大影响。